November 16 - 17, 2011    london , United Kingdom
TAC2011 will address the critical scientific issues and challenges associated with developing targeted therapeutic antibodies for cancer. It will highlight improvements in antibody development, global trends and current clinical progress.

Benefits of attending TAC 2011:

• Hear about the latest trends in antibody therapeutics for cancer: antibodies to watch in 2011 and the future
• Join in with the discussion about what biosimilars will mean for the pharma industry
• Understand the best strategies for improving antibody production
• Receive practical advice about taking antibodies from concept to reality with instructive case studies highlighting successful new antibodies in development
• Examine how to capture the potential of personalised antibody therapies for cancer
• Assess bispecific, trifunctional, radiolabelled antibodies and antibody-drug conjugates in the treatment of cancer
• Network with leading experts in the field and build up your business prospects

Venue

Location: etc venues Paddington
Two floors of superb, canalside training, meeting and conference space in Paddington Basin.
Contact 241 Borough High Street London SE1 1GA london , United Kingdom
020 7105 6090

Related events

Targeted Antibodies for Cancer (TAC) November 16 - 17, 2011